The ARMONACT brand, founded in 2005 (Japan), from 440 sister brands and 4958 competing brands. ARMONACT is owned by Takeda Pharmaceutical, listed on the stock exchange of Francfort The ISIN, the company's International Securities Identification Number, is JP3463000004. ARMONACT is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(ARMONACT)
over 5 years*
EUR 18.63